www.camurus.com
Open in
urlscan Pro
104.46.36.9
Public Scan
Submitted URL: http://camurus.com/
Effective URL: https://www.camurus.com/
Submission: On February 20 via api from US — Scanned from NL
Effective URL: https://www.camurus.com/
Submission: On February 20 via api from US — Scanned from NL
Form analysis
1 forms found in the DOM/search/
<form action="/search/">
<input aria-label="Search" class="_searchbox" placeholder="Search" name="q" value="" autocomplete="off"><button aria-label="Submit search"></button>
<div class="_instantsearch" data-nohits="No results found"></div>
</form>
Text Content
Skip to main contentSkip to navigationSkip to search * About us * Contact us * About us * Our commitment * Business model * Board of directors * Management team * Code of conduct * Science * * Science * Products * R&D pipeline * Technology * Disease areas * Read Will's story * Disease areas * Opioid dependence * Acromegaly * Polycystic liver disease * Neuroendocrine tumors * Sustainability * Investors * * Investors * The share * Press releases * Events and presentations * Capital Markets Day * Financial calendar * Financial reports * Corporate governance * Committees * Remuneration * General meetings * Auditors * Incentive programs * Articles of association * Nomination Committee * AGM * General meetings * CEO message * IPO and Prospectus * Investor contact * Partnering * Media * * Media * Press releases * Media contact * Media archive * Career * Contact English EnglishSvenska DELIVERING BETTER TREATMENTS Camurus is committed to improving the lives of patients with severe and chronic diseases Read more UPDATES LATEST NEWS All press releases 14 February 2023 CAMURUS’ FULL YEAR REPORT 2022 Regulatory 13 February 2023 CAMURUS WITHDRAWS VARIATION APPLICATION FOR CAM2038 TO INCLUDE CHRONIC PAIN Press release Regulatory 30 December 2022 CHANGE IN NUMBER OF SHARES AND VOTES IN CAMURUS Press release Regulatory All press releases Disease areas FOCUS ON SEVERE AND CHRONIC DISEASES Developing treatments for diseases within the central nervous system, rare diseases, endocrinology, oncology and supportive care Learn more on disease areas Events UPCOMING EVENTS See all events * 15 Mar CARNEGIE HEALTHCARE SEMINAR 2023 Camurus’ President & CEO Fredrik Tiberg is presenting at this conference on 15 March, at 1.45pm CET, Stockolm, Sweden. The presentation can be seen by the conference participants. Add to calendar * 20 Mar BIO-EUROPE SPRING 2023 Camurus will participate in this conference in Basel, Switzerland, 20-22 March, 2023. Add to calendar * 30 Mar ANNUAL REPORT 2022 The Annual Report 2022 is published on 30 March 2023. Add to calendar Latest financial report CAMURUS’ FULL YEAR REPORT 2022 14 February 2023 * Report Camurus’ Full Year Report 2022 * Presentation Camurus’ Full Year Report 2022 * Audiocast Camurus’ Full Year Report 2022 Go to report archive Products ADDRESSING IMPORTANT UNMET MEDICAL NEEDS Learn about our products Stories LIVING WITH OPIOID DEPENDENCE Read Will's story Pipeline DIVERSIFIED PIPELINE WITH LARGE POTENTIAL Camurus' innovative product candidates are designed to address important unmet medical needs, with the potential to make significant difference in the daily life of patients by improving treatment outcomes, quality of life, and long-term recovery. See pipeline sustainability SUSTAINABLE SOLUTIONS FOR A HEALTHIER WORLD Ensuring the long-term successful development of our business – for the benefit of patients, healthcare systems, employees and shareholders Learn more QUICKLINKS * Contact * About us * Pipeline * Products INVESTORS * Press releases * Financial reports * IR contact ADDRESS Camurus AB Ideon Science Park SE-223 70 Lund, Sweden * Terms of Use * Privacy notice * Cookie policy Camurus AB - all rights reserved English EnglishSvenska This website uses cookies to provide the best possible user experience. By accepting you consent to cookies being used. Read more about cookies here Accept